Difference between revisions of "CT Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
(29 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Chairs: Gregory Goldmacher, MD, PhD, MBA (Co-Chair), Lawrence Schwartz, MD (Co-chair), David Lynch, MD (Vice-chair)
+
Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE;  James L. Mulshine, MD
:Secretary: Susan Weinmann (RSNA Staff)
+
<br />RSNA Staff Support: Julie Lisiecki 
:Roster: ''<link to roster of active attendees and who has voting privileges>''
+
* [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster''']
 +
 
  
 
==Scope==  
 
==Scope==  
Line 10: Line 11:
 
:* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
 
:* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
 
::* [[CT Volumetry Biomarker Ctte]]
 
::* [[CT Volumetry Biomarker Ctte]]
 +
:::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]]
 
::* [[Lung Density Biomarker Ctte]]
 
::* [[Lung Density Biomarker Ctte]]
  
 
==Meetings==
 
==Meetings==
  
* Tcons are held Quarterly. Contact the secretary for details.
+
* WebEx calls are held Quarterly. Please contact RSNA Staff for details.
* [[CT CC Call Summaries]]
 
 
 
==Current Work==
 

Revision as of 23:33, 24 February 2021

Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
RSNA Staff Support: Julie Lisiecki


Scope

The CT Coordinating Committee coordinates Biomarker Committees based on CT.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees

Meetings

  • WebEx calls are held Quarterly. Please contact RSNA Staff for details.